VERIFIEDEconomic Times News·27 Jul 2026negative

US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipeline

AI Summary

·Dr Reddy's and Cipla reported decreased net profits and operating margins in the June quarter due to a decline in their US business.
·Both companies experienced strong performance in their domestic markets.
·Future growth is anticipated from obesity therapies and specialty product launches, though analysts have lowered earnings forecasts.